Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, Conestoga Capital Advisors Mid Cap ...

Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) develops, manufactures, and distributes products for the companion ...

Currently, IDEXX Laboratories shares are trading down 0.29%, priced at $623.13 during Friday's morning. This values ...

The latest update on Thursday morning shows IDEXX Laboratories shares down by 1.53%, trading at $638.83. At this price, Fennell's 12,821 shares are worth $7,320,534.

IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the strong momentum in its CAG (Companion Animal Group) Diagnostics business. The company is also growing its ...

We came across a bullish thesis on IDEXX Laboratories, Inc. on MTC’s Substack. In this article, we will summarize the bulls’ ...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best medical technology stocks to invest in. On February 3, BTIG lowered its price target on IDEXX Laboratories Inc.

IDEXX Laboratories, Inc. (IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market return. The last ...

Baron Funds, an investment management company, released its “Baron Partners Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund rose modestly in the second ...